Navigation Links
SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
Date:7/7/2011

WOOD DALE, Ill. and FRANKLIN LAKES, N.J., July 7, 2011 /PRNewswire/ -- SANYO North America Corporation (SANYO) Biomedical Solutions Division and BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced a strategic agreement today to jointly promote cutting-edge life science research tools designed to advance cell culture and cell therapy research, which will help them expand their presence in the cell therapy, cell culture and overall life sciences markets.

"Leveraging our collective strengths, SANYO and BD Biosciences aim to continually advance products that help research and development," said SANYO Biomedical Solutions division President Toshiaki Inoue. "This collaboration will enable us to offer our customers more value by integrating our existing products and technologies as well as exploring new cell therapy research tools."  

The goals of this collaboration are to develop long-term and short-term co-marketing programs, as well as to research innovative ways to combine product technologies and offerings to serve both current and untapped market applications. SANYO will integrate with BD Biosciences' SySTEMatic ExCELLence(SM) marketing campaign.

"This collaboration reflects BD Biosciences' commitment to delivering best-in-class, highly integrated products and services to help life scientists reduce risk and ensure superior quality, while producing clinical-grade stem cell applications," said Bill Rhodes, President, BD Biosciences.

The two businesses will work together to grow current and future business by combining SANYO CO2 incubators with specialized BD Biosciences - Discovery Labware products. They will also combine SANYO refrigerators and freezers with BD Advanced Bioprocessing cell culture media and supplements for multiple research applications.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world.  BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines.  The Company's capabilities are instrumental in combating many of the world's most pressing diseases.  Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world.  The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.  For more information, please visit http://www.bd.com.

About SANYO

SANYO Electric Co., Ltd. is a global, leading provider of energy, environment, and lifestyle applications. Biomedical Solutions, a Division of SANYO North America Corporation (a subsidiary of SANYO Electric Co., Ltd.), is based in Wood Dale, IL, and provides laboratory equipment for pharmaceutical, life science and biotechnology applications. Product lines include space-efficient VIP® ultra-low temperature freezers, cryogenic freezers, pharmaceutical and medical refrigerators, cell culture incubators, plant growth chambers, and portable autoclaves.

To learn more about SANYO, please visit http://us.sanyo.com.


'/>"/>
SOURCE SANYO North America Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools
2. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
3. Genesis Biosciences Receives Pulire Innovation Award for e card Sanitary Bin Treatment Product
4. Avantra Biosciences Announces Significant Reduction In Multiplex Immunoassay Processing Time
5. Avantra Biosciences Announces the Launch of a Rapid Assay Prototyping Service
6. GeneLink Biosciences Expands its Scientific Advisory Board to Support New Product Lines
7. Ardea Biosciences to Present at Upcoming Investor Conferences
8. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
9. Magellan Biosciences to Present at Medicaid Health Plans of America Center for Best Practices First Annual Awards Forum
10. TEI Biosciences Wins SBANE 2011 New England Innovation Award
11. Transposagens piggyBac™ Vectors to be Distributed by System Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- Partnering to fuel Philadelphia,s innovative ... Southeastern Pennsylvania (" Ben Franklin "); ... Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... million funding initiative over a four year period to ... a burgeoning economic vitality in digital health, Ben ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, ... escalation and expansion clinical trial for its lead drug candidate, AC0010, at the ... the trial was to determine the safety, antitumor activity, and recommended phase II ...
(Date:12/7/2016)... Lincoln, NE (PRWEB) , ... December 07, 2016 ... ... control systems integration, today announced that it has become a Wonderware Certified System ... Wonderware System Integrator Partner by Schneider Electric Software. , “The System Integrator Partner ...
(Date:12/7/2016)... - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company focused ... for the treatment of cancer, today announced that ... Program with Cytovance Biologics ( Oklahoma City, ... product. Supported by recent positive interim clinical results ... cancer patients, OncoQuest has engaged Cytovance to establish ...
Breaking Biology Technology:
(Date:12/8/2016)... , Dec. 8, 2016 Market Research Future published a ... The global Mobile Biometric Security and Service Market is expected to ... 2022. Market Highlights: ... , Mobile Biometric Security ... to the increasing need of authentication and security from unwanted cyber ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
(Date:12/7/2016)... , December 7, 2016 According to a new ... Learning), Software Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And ... estimated to grow from USD 6.72 Billion in 2016 to USD 36.07 Billion ... Continue Reading ... ...
Breaking Biology News(10 mins):